Operating income decreased 113.0%
Operating income changed -113.0% from the comparable as-filed period.
-$7.1M→-$15.1M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →OPTT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy decreased 46.8%
Free-cash-flow proxy changed -46.8% from the comparable as-filed period.
-$7.1M→-$10.4M3 prior comparisons
Operating cash flow decreased 82.7%
Operating cash flow changed -82.7% from the comparable as-filed period.
-$5.6M→-$10.2M3 prior comparisons
Gross margin moved 94172 bp lower
Gross margin changed -94172 basis points from the comparable as-filed period.
-1.95%→-943.67%3 prior comparisons
Operating margin moved 442685 bp lower
Operating margin changed -442685 basis points from the comparable as-filed period.
-598.82%→-5025.67%3 prior comparisons
Net income decreased 42.6%
Net income changed -42.6% from the comparable as-filed period.
-$7.4M→-$10.5M3 prior comparisons
Revenue decreased 74.6%
Revenue changed -74.6% from the comparable as-filed period.
$1.2M→$300,0003 prior comparisons
Cash & equivalents decreased 25.4%
Cash & equivalents changed -25.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$9.9M→$7.4M3 prior comparisons
Cost of revenue increased 276.3%
Cost of revenue changed +276.3% from the comparable as-filed period.
$1.2M→$4.5M3 prior comparisons
Stock-based compensation decreased 23.8%
Stock-based compensation changed -23.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$2.4M→$1.8M3 prior comparisons
Stockholders' equity decreased 65.1%
Stockholders' equity changed -65.1% from the comparable as-filed period.
$24.2M→$8.5M2 prior comparisons
Current liabilities increased 154.1%
Current liabilities changed +154.1% from the comparable as-filed period.
$11.6M→$29.5M3 prior comparisons
SBC / revenue moved 40671 bp higher
SBC / revenue changed +40671 basis points from the comparable as-filed period.
202.96%→609.67%3 prior comparisons
Trade receivables decreased 43.4%
Trade receivables changed -43.4% from the comparable as-filed period.
$2.2M→$1.2M2 prior comparisons
Capex / revenue moved 8159 bp lower
Capex / revenue changed -8159 basis points from the comparable as-filed period.
122.93%→41.33%3 prior comparisons
Capital expenditure decreased 91.5%
Capital expenditure changed -91.5% from the comparable as-filed period.
$1.5M→$124,0003 prior comparisons
Inventory / revenue moved 110574 bp higher
Inventory / revenue changed +110574 basis points from the comparable as-filed period.
411.59%→1517.33%3 prior comparisons
Free-cash-flow proxy decreased 72.3%
Free-cash-flow proxy changed -72.3% from the comparable as-filed period.
-$4.0M→-$6.8M1 prior comparisons
Operating income decreased 55.2%
Operating income changed -55.2% from the comparable as-filed period.
-$5.9M→-$9.1M1 prior comparisons
Operating cash flow decreased 81.6%
Operating cash flow changed -81.6% from the comparable as-filed period.
-$3.7M→-$6.8M1 prior comparisons
Gross margin moved 17105 bp lower
Gross margin changed -17105 basis points from the comparable as-filed period.
23.88%→-147.17%1 prior comparisons
Operating margin moved 106527 bp lower
Operating margin changed -106527 basis points from the comparable as-filed period.
-712.12%→-1777.39%1 prior comparisons
Research & development decreased 53.8%
Research & development changed -53.8% from the comparable as-filed period.
$1.3M→$600,0002 prior comparisons
Cash & equivalents decreased 29.6%
Cash & equivalents changed -29.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$10.0M→$7.1M2 prior comparisons
Net income decreased 69.1%
Net income changed -69.1% from the comparable as-filed period.
-$6.7M→-$11.4M1 prior comparisons
Revenue decreased 37.8%
Revenue changed -37.8% from the comparable as-filed period.
$825,000→$513,0001 prior comparisons
Inventory increased 32.6%
Inventory changed +32.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$3.9M→$5.2M2 prior comparisons
Shares outstanding increased 34.1%
Shares outstanding changed +34.1% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes.
170,050,563→228,023,4397 prior comparisons
Working capital decreased 88.7%
Working capital changed -88.7% from the comparable as-filed period.
$12.5M→$1.4M2 prior comparisons
Capex / revenue moved 2009 bp lower
Capex / revenue changed -2009 basis points from the comparable as-filed period.
26.91%→6.82%1 prior comparisons
Capital expenditure decreased 84.2%
Capital expenditure changed -84.2% from the comparable as-filed period.
$222,000→$35,0001 prior comparisons
Current liabilities increased 353.6%
Current liabilities changed +353.6% from the comparable as-filed period.
$4.3M→$19.7M2 prior comparisons
Stock-based compensation increased 225.0%
Stock-based compensation changed +225.0% from the comparable as-filed period.
$800,000→$2.6M1 prior comparisons
Current assets increased 25.4%
Current assets changed +25.4% from the comparable as-filed period.
$16.8M→$21.1M2 prior comparisons
Trade receivables increased 277.1%
Trade receivables changed +277.1% from the comparable as-filed period.
$1.6M→$6.1M1 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.